$GLIBK

GCI Liberty, Inc.

No enriched coverage for $GLIBK in the last 7 days.

No SEC Form 4 filings for $GLIBK in the last 30 days.

Med

GCI Liberty, Inc. - Series C GCI Group (NASDAQ:GLIBK) Hits New 52-Week High - Should You Buy?

GCI Liberty, Inc. - Series C GCI Group (NASDAQ:GLIBK) reached a new 52-week high of $39.94, trading up approximately 2.4% with a market capitalization of $1.15 billion. Despite this performance, analyst sentiment is mixed, with the stock holding a "Reduce" rating from MarketBeat. Recent insider and institutional buying, including a significant purchase by Director Jedd Gould and new positions from major firms, indicates some confidence in the stock.

GCI Liberty, Inc. - Series C GCI Group (NASDAQ:GLIBK) Sees Large Decline in Short Interest

GCI Liberty, Inc. - Series C GCI Group (NASDAQ:GLIBK) experienced a significant 38.2% decline in short interest in December, bringing the total to 981,427 shares, or about 3.4% of shares sold short. This decrease implies a days-to-cover ratio of approximately 1.2 days based on average trading volume. The article also highlights a recent insider purchase by Director Jedd Gould and a ratings downgrade from Weiss Ratings from "buy" to "hold".

News on $GLIBK